Stay updated on Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T20:05:10.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. There are no changes to the study content or user-facing information on the page.
    Difference
    0.0%
    Check dated 2026-03-07T13:12:17.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. This appears to be a minor software version update with no visible changes to the study information.
    Difference
    0.0%
    Check dated 2026-02-13T18:14:42.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:36:30.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Revision: v3.4.1 appears on the page, replacing v3.4.0; there are no visible changes to trial content or details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T14:20:31.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    Show glossary option added to the page interface. Minor text updates include capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data,' and the revision version updated from v3.3.4 to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-29T06:22:52.000Z thumbnail image

Stay in the know with updates to Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page.